Senior insider sale
CEO at EDITAS MEDICINE, INC. — senior position signals high conviction
$65.9K
36.63K shares
What this filing means
O'NEILL GILMORE NEIL plans to sell 36.63K shares of EDITAS MEDICINE, INC. valued at approximately $65.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/2/2025ACC: 0001650664-25-000087
DirectorOfficer· CEO
Since Jun 2022
36.63K
Shares to sell
$65.9K
Approx. market value
32.96K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Equity Compensation
6/2/2025
32.96KTotal acquired32.96K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/2/2025 | Restricted Stock Unit Vesting Equity Compensation | 32.96K | — |
| Total | 32.96K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
16.63K
Market value
$28.5K
3/4/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
20K
Market value
$37.4K
6/3/2025
Total
Units
36.63K
Value
$65.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/4/2025 | 16.63K | $28.5K | — | Completed |
| Planned — Approximate Date | ||||
6/3/2025 | 20K | $37.4K | NASDAQ | Planned |
| Total | 36.63K | $65.9K | ||